# K022983: Bardport X-Port Isp Port

- Pathway: 510(k) (Special)
- Applicant: C.R. Bard, Inc.
- Decided: Sep 25, 2002 after 16 days
- Product code: LJT (Port & Catheter, Implanted, Subcutaneous, Intravascular)
- Device class: 2
- Regulation: 21 CFR 880.5965
- Recalls of this device: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K873213 (1987). 1 ancestor in all.
2 later devices descend from it; 2 cite it directly.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K873213: Hickman Plastic Subcutaneous Port, C.R. Bard, Inc. (1987) Summary page 1.

## Most influential descendants
- K153359: BardPort®, SlimPort®, and X-Port® Implanted Ports (2016), 0 descendants of its own
- K133335: Powerport Implantable Port (2014), 0 descendants of its own

## Recalls of this device
- Oct 1, 2019 · Class II · Z-1578-2020: Firm has identified that the product may be at risk of incorrectly containing a tunneler with a barb tip meant to attach to a 6Fr catheter instead of the correct barb tip for a 9.6Fr catheter. This ca

## Indications for use
The Bardport® and SlimPort™ Implanted Ports are indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, I.V. fluids, parenteral nutrition solutions, blood products and for the withdrawal of blood samples.

Source page: https://510kreport.com/device/K022983
Methodology: https://510kreport.com/methodology